Seeking Alpha

Perrigo (PRGO -0.3%) has received FDA approval to market polacrilex, its OTC mini nicotine...

Perrigo (PRGO -0.3%) has received FDA approval to market polacrilex, its OTC mini nicotine lozenges. The mint flavored mini lozenge will be marketed under retailer and wholesalers'store, or own brand labels, and is comparable to GlaxoSmithKline's (GSK -0.3%) Nicorette Mini Lozenge. PRGO says is lozenge is the first product approved that will target the individual store brand market.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|